Cue Biopharma Receivables

Cue Biopharma (CUE) currently reports a receivables of $5.4M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Cue Biopharma's receivables history and peer comparisons.

Cue Biopharma's receivables changed from $0 to $5.4M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cue Biopharma reported $5.4M in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $5.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cue Biopharma, and consider following CUE for alerts when major investors trade the stock.

Cue Biopharma is classified in the Healthcare sector. On receivables, it currently shows $5.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CUE with unrelated industries.